- Market Capitalization, $K 51,535
- Shares Outstanding, K 15,160
- Annual Sales, $ 47,530 K
- Annual Income, $ -3,540 K
- 60-Month Beta 0.42
- Price/Sales 1.06
- Price/Cash Flow 6.41
- Price/Book 1.01
|Period||Period Low||Period High||Performance|
| || |
+0.14 (+4.32%)since 07/02/20
| || |
-0.62 (-15.50%)since 05/04/20
| || |
-2.73 (-44.73%)since 08/02/19
, /PRNewswire/ -- (NASDAQ: CPIX) announced today that it will release second quarter 2020 financial results and Company update after the market closes on . A conference call and live internet webcast...
, /PRNewswire/ -- Cumberland Pharmaceuticals Inc. a specialty pharmaceutical company, today announced the results of a Level 1 Trauma Center study recently published in the Journal of Orthopedic Trauma....
Cumberland (CPIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
, /PRNewswire/ -- , a U.S. specialty pharmaceutical company, announces a new publication in , detailing the positive clinical outcomes with Vibativ in treating patients with bacteremia or endocarditis....
Cumberland (CPIX) delivered earnings and revenue surprises of -50.00% and -11.93%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
NASHVILLE, Tenn. (AP) _ Cumberland Pharmaceuticals Inc. (CPIX) on Wednesday reported a loss of $1.1 million in its first quarter.
, /PRNewswire/ -- (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today provided a company update and announced first quarter 2020 financial results....
, /PRNewswire/ -- announced today that it will release first quarter 2020 financial results and a Company update after the market closes on . A conference call and live Internet webcast will be held...
Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast
Here are four top-ranked liquid gems that investors can add to portfolio for remarkable returns.